The inhibitory effect of cinnarizine on calciuminduced vascular contraction (Godfraind & Kaba 1972 ) has been suggested as the possible mode of action to explain the potentiation by cinnarizine of vascular hyperwmic responses to ischmmia (Schuermans et al. 1971) . In patients with intermittent claudication, cinnarizine has been shown to improve exercise performance (Simoes Neto 1971 , Barraine et al. 1970 . The aim of this study was to investigate the vascular responses to standard exercise before, during and after cinnarizine in patients with obstructive arterial disease. The study was designed to examine the temporal patterns of onset of action and persistence following cinnarizine withdrawal. An ECG-triggered plethysmograph was used to monitor blood flow changes.
PATIENTS AND METHODS

Subjects
Ten men were studied. Their ages ranged from 50 to 68 years (mean 62 years) and they were, suffering from moderate to severe intermittent claudication due to severe atherosclerotic disease of the lower limbs. Aortography revealed that 9 had unilateral involvement; in one, both legs were affected. All had a history of long-standing cigarette smoking (20-50 years) with an average consumption of 20 cigarettes/day. The regular alcohol intake was modest. Prior to the study all vasoactive drugs were discontinued.
Study Design
Each patient was studied for a 21 day period comprising 3 consecutive phases, each of 7 days.
Period I was a 7-day pre-drug baseline phase. In Period II, cinnarizine was administered (75 mg three times daily) for 7 days and then withdrawn, and the observations were continued for a further 7 days (Period III). During each period plethysmography was conducted at rest and after 1, 3 and 10 min following a 5 min period of standard exercise. During the baseline Period 1, 3 plethysmographic measurements wei e made on days 1, 3 and 7. The first served as a run-in and was not included in the statistical analysis. During Periods II and III, tests were made after 3 and 7 days. At the end of each period patients were asked to complete a multi-choice questionnaire to record their subjective response and unwanted effects. Before and after the cinnarizine period, blood and urine samples were collected for routine hlmatology, biochemistry and urinalysis.
Procedure for Plethysmography
The ECG-triggered venous occlusion plethysmograph (Janssen Scientific Instruments Division) was used as a semi-continuous indirect measure of arterial inflow. Plethysmography was carried out after the patient had been resting supine for 1 h in a room maintained at a constant temperature of 23-24°C, with both legs elevated at an angle of 15°. Strain gauges (mercury-filled silastic tubes of external diameter 0.64 mm and internal diameter 0.3 mm) were fixed on each calf, approximately 20 cm from the ankles. Sphygmomanometer cuffs were applied to each thigh, the positions of strain gauges and cuffs being marked for repeat measurements.
Using ECG triggering, flow measurements were made in every cycle of 10 heart beats. Venous occlusion from rapid inflation of the cuff to 50 mmHg occurred for 5 beats, followed by a recovery period of 5 heart beats. Arterial flow was determined from the average of 10 cycles obtained at rest and at 1, 3 and 10 min after an exercise period of 5 min. A foot exerciser mounted at the end of the couch was used for this purpose. The patient pressed each foot plate alternately against a load of 10% of body weight applied to the two foot plates. The exercise rate was standardized to 30 movements/min with the aid of a metronome. The design of the foot exerciser used is shown in Fig 1. Analysis ofResults For statistical analysis, a Wilcoxon matched pairs rank test (one-tailed probability) was used to examine the paired series of data, the changes in flow at rest and hyperwmic flow during baseline, drug and post-drug periods. The right and left limbs were analysed separately. 
Resting Blood Flow
Mean values for both limbs during the cinnarizine and post-cinnarizine periods compared with the control period are given in Table 1 , together with the results of statistical analysis. The duplicate measurements on days 3 and 7 of the control period showed no significant difference and thus these two values were combined. Cinnarizine significantly increased resting flow from the third day of treatment in the 10 right limbs. The increase was 35% (P<0.005) and the effect was maintained on day 7. In the 8 left limbs, control resting flow was higher than recorded in the right limbs, and was increased during cinnarizine treatment, although the response was less marked and more variable. Three days after withdrawal of cinnarizine, blood flow in both limbs was still elevated, but had returned to baseline control values by the seventh day.
Hyperamic Blood Flow
Control period: Table 2 shows the changes in mean resting flow after one, 3 and 10 min of exercise. This demonstrates that hyper2mic blood flow reached a maximum value I min after the exercise, with mean increases of 39% for right limbs and 15% for left limbs. At 3 and 10 min, Cinnarizine and withdrawal periods: During cinnarizine therapy, hyper2mic blood flow showed an increase over post-exercise controls 1 min after exercise (Table 3 ). The improvement in response shown during cinnarizine treatment was progressive from the third to the seventh day. By the end of treatment there was a 72% increase for right limbs and 59% for left limbs, a statistically significant improvement compared to control values (P<0.01). At 3 and 10 min postexercise, blood flow was also significantly enhanced. Three days after withdrawal of drug, blood flow was still greater than control values but had returned to baseline levels 7 days after withdrawal (Fig 2) .
Subjective assessments: Tables 4 and 5 show the results of the patients' symptom questionnaire after 7 days ofcinnarizine treatment.
Side effects: Two patients complained of mild drowsiness whilst on cinnarizine. Throughout the study there were no abnormal variations in individual blood pressure measurements (range 123/74-176/98 mmHg). Heematology, biochemistry and urinalysis were not modified by the administration ofcinnarizine.
Discussion
The patients in this study had readily demonstrable intermittent claudication in an advanced stage. Table 5 Patients' subjective assessment of well-being after 7 days of cinarizine treatment Very well Well Unchanged Poor I 5 3 1 Havard (1971) for an affliction of long-standing cigarette smoking in men. Previous plethysmographic studies have demonstrated a decreased blood flow and diminished vascular responsiveness in such patients (Verhaegen et al. 1976 ). The relatively new technique of ECG triggering with short occlusion and recovery periods (as suggested by Barendsen et al. 1971) , allows semi-continuous blood flow measurements without the variability induced by vasoactive metabolites during the long period of occlusion (Strandness & Bell 1965) . The placing of strain gauges over the same calf muscle site allowed repeated and more reproducible measurements of muscle blood flow to be made. These results clearly indicate that cinnarizine improves blood flow in the vasculature by increasing resting flow and potentiating and prolonging hyperaemic blood flow induced after standard exercise of the calf muscles. Improvement was normally shown in both limbs, but usually the less severely affected limbs were more responsive to cinnarizine. This suggests that the patients likely to have the best response are those who are treated relatively early in the disease process, before major arterial stenosis has become a surgical problem. By the third day of treatment considerable drug activity was seen, which further increased as treatment progressed. A carry-over effect lasting for approximately 7 days was apparent on stopping cinnarizine. The objective increases in blood flow agreed well with the subjective assessments made by the patients themselves. There was considerable improvement in well-being and walking distances in 60% of cases. 
Summary
Ten patients with angiographic confirmation of intermittent claudication secondary to peripheral atherosclerosis were studied before, during and after cinnarizine administration (225 mg daily for 7 days). During each of the 3 periods, venous occlusion plethysmography (ECG triggered) was conducted at rest and 1, 3 and 10 min after a standard 5 min pedal exercise. Cinnarizine increased resting flow approximately 35 % and potentiated and prolonged hyperemic flow. These effects increased gradually from the third to the seventh day of treatment. On withdrawal of cinnarizine, rest and hypermmic blood flow remained elevated but by 7 days had returned to base-line control values. The improved vascular status of the calf muscles during cinnarizine treatment was reflected by subjective improvement, 60% of the patients recording an increased walking distance and feeling of wellbeing.
